The Correlation Between the Subsets of Tumor Infiltrating Memory T Cells and the Expression of Indoleamine 2,3-Dioxygenase in Gastric Cancer

被引:35
|
作者
Zhang, Rupeng [1 ]
Liu, Hui [1 ]
Li, Fangxuan [2 ]
Li, Hui [3 ]
Yu, Jinpu [3 ]
Ren, Xiubao [3 ]
机构
[1] Tianjin Med Univ Canc Inst & Hosp, Dept Gastr Canc Surg, Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China
[2] Tianjin Med Univ Canc Inst & Hosp, Canc Prevent Ctr, Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China
[3] Tianjin Med Univ Canc Inst & Hosp, Dept Immunol, Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China
关键词
Tumor-infiltrating T cells; Indoleamine 2,3-dioxygenase; Memory T cells; Gastric cancer; PROTECTIVE IMMUNITY; ANTITUMOR IMMUNITY; COLORECTAL-CANCER; LYMPHOCYTES; MTOR; INHIBITION; DIFFERENTIATION; PROLIFERATION; SUPPRESSION; ACTIVATION;
D O I
10.1007/s10620-013-2837-0
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Although many researchers have concentrated on the mechanism of T cell anergy resulting from over-expression of Indoleamine 2,3-dioxygenase (IDO), it remains unclear what alterations will developed in memory T cells (Tm) under over-expression of IDO. Immunohistochemical staining for IDO expression in gastric cancer tissues (n = 50) was carried out. Tumor-infiltrating memory Tm cells were counted by flow cytometry. The association between IDO expression and the subsets of tumor infiltrating Tm are discussed. The higher IDO expressions were significantly associated with deeper invasion (P = 0.016) and higher frequencies (P = 0.038) of lymph node metastasis. The lower tumor-infiltrating CD4(+)Tm were significantly associated with the advanced clinical stage (P = 0.026) and lymph node metastasis (P = 0.016). The lower percentages of CD8(+)Tm were significantly related to undifferentiated histological type (P = 0.042) and lymph node metastasis (P = 0.037). However, the lower percentage of CD8(+)Tem was significantly correlated to differentiated histological type (P = 0.017), lower frequencies of lymph node metastasis (P = 0.014), and earlier clinical stage (P = 0.008). The higher IDO expression patients had significantly lower percentages of CD4(+)Tm (P = 0.012) and CD8(+)Tm (P = 0.033). Nevertheless, it was confirmed that the higher level of IDO expression correlated with higher percentages of CD8(+)Tm cells in univariate and multivariate analysis (P = 0.011). IDO over-expression and Tm in tumor microenvironments were correlated with the disease stage and histological type of gastric cancer. Higher IDO expression was related to the lower percentage of CD4(+)Tm and CD8(+)Tm, whereas the higher level of IDO expression related with a higher percentage of CD8(+)Tem.
引用
收藏
页码:3494 / 3502
页数:9
相关论文
共 50 条
  • [31] Inhibition of indoleamine 2,3-dioxygenase enhances the T-cell response to influenza virus infection
    Fox, Julie M.
    Sage, Leo K.
    Huang, Lei
    Barber, James
    Klonowski, Kimberly D.
    Mellor, Andrew L.
    Tompkins, S. Mark
    Tripp, Ralph A.
    JOURNAL OF GENERAL VIROLOGY, 2013, 94 : 1451 - 1461
  • [32] Interferon-γ-triggered indoleamine 2,3-dioxygenase competence in human monocyte-derived dendritic cells induces regulatory activity in allogeneic T cells
    Juergens, Birgit
    Hainz, Ursula
    Fuchs, Dietmar
    Felzmann, Thomas
    Heitger, Andreas
    BLOOD, 2009, 114 (15) : 3235 - 3243
  • [33] Resveratrol suppresses tumor progression via the regulation of indoleamine 2,3-dioxygenase
    Noh, Kyung Tae
    Chae, Seung Hoon
    Chun, Sung Hak
    Jung, In Duk
    Kang, Hyun Kyu
    Park, Yeong-Min
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 431 (02) : 348 - 353
  • [34] Indoleamine 2,3-Dioxygenase 1: A Promising Therapeutic Target in Malignant Tumor
    Song, Xiaotian
    Si, Qianqian
    Qi, Rui
    Liu, Weidan
    Li, Miao
    Guo, Mengyue
    Wei, Lin
    Yao, Zhiyan
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [35] Involvement of Indoleamine 2,3-Dioxygenase in Impairing Tumor-Infiltrating CD8+ T-Cell Functions in Esophageal Squamous Cell Carcinoma
    Zhang, Ge
    Liu, Wan-Li
    Zhang, Lin
    Wang, Jun-Ye
    Kuang, Miao-Huan
    Liu, Peng
    Lin, Yue-Hao
    Dai, Shu-Qin
    Du, Jun
    CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2011,
  • [36] Indoleamine 2,3-dioxygenase (IDO) induced by Leishmania infection of human dendritic cells
    Donovan, M. J.
    Tripathi, V.
    Favila, M. A.
    Geraci, N. S.
    Lange, M. C.
    Ballhorn, W.
    McDowell, M. A.
    PARASITE IMMUNOLOGY, 2012, 34 (10) : 464 - 472
  • [37] Indoleamine 2,3-dioxygenase expression and overall survival in patients diagnosed with breast cancer in Pakistan
    Asghar, Kashif
    Loya, Asif
    Rana, Iftikhar Ali
    Tahseen, Muhammad
    Ishaq, Muhammad
    Farooq, Asim
    Abu Bakar, Muhammad
    Masood, Iqra
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 475 - 481
  • [38] Lipopolysaccharide-induced indoleamine 2,3-dioxygenase expression in the periodontal ligament
    Moon, J. S.
    Cheong, N. R.
    Yang, S. Y.
    Kim, I. S.
    Chung, H. J.
    Jeong, Y. W.
    Park, J. C.
    Kim, M. S.
    Kim, S. H.
    Ko, H. M.
    JOURNAL OF PERIODONTAL RESEARCH, 2013, 48 (06) : 733 - 739
  • [39] Indoleamine-2,3-dioxygenase elevated in tumor-initiating cells is suppressed by mitocans
    Stapelberg, Michael
    Zobalova, Renata
    Nguyen, Maria Nga
    Walker, Tom
    Stantic, Marina
    Goodwin, Jacob
    Pasdar, Elham Alizadeh
    Thai, Thuan
    Prokopova, Katerina
    Yan, Bing
    Hall, Susan
    de Pennington, Nicholas
    Thomas, Shane R.
    Grant, Gary
    Stursa, Jan
    Bajzikova, Martina
    Meedeniya, Adrian C. B.
    Truksa, Jaroslav
    Ralph, Stephen J.
    Ansorge, Olaf
    Dong, Lan-Feng
    Neuzil, Jiri
    FREE RADICAL BIOLOGY AND MEDICINE, 2014, 67 : 41 - 50
  • [40] Prognostic value of indoleamine 2,3-dioxygenase activity and expression in nasopharyngeal carcinoma
    Ben-Haj-Ayed, Ahlem
    Moussa, Adnene
    Ghedira, Randa
    Gabbouj, Sallouha
    Miled, Souad
    Bouzid, Nadia
    Tebra-Mrad, Sameh
    Bouaouina, Noureddine
    Chouchane, Lotfi
    Zakhama, Abdelfattah
    Hassen, Elham
    IMMUNOLOGY LETTERS, 2016, 169 : 23 - 32